Site/Sponsor Relationships
Advarra’s Support for Institutions
Find out how we keep site centricity at the forefront through our technology, services, and extraordinary team members.
Beginner’s Guide to Institutional Review Boards (IRBs)
In the U.S., there is an independent group overseeing clinical research, ensuring participants’ rights and welfare are protected.
eClinical Regulatory Trends Impacting Clinical Research
Understand current regulatory trends in clinical research and how it will shape the industry moving forward.
Beginner’s Guide to Community-Based Participatory Research
Learn what CBPR is, how it's employed, the benefits of conducting it, & how to best approach this type of research.
It’s Time for Sites to “Bring Your Own Technology” (BYOT)
The Bring Your Own Technology philosophy will produce synchronization between sites & sponsors, which improves both care & clinical outcomes.
Advarra Research-Ready Training Services
Advarra’s Research-Ready Training applies effective and innovative eLearning techniques for required research topics.
The Advantages of Outsourcing IRB and IBC Reviews to One Partner
By utilizing a vendor that offers both IRB and IBC services in-house, sponsors can streamline reviews and enhance study startup timelines.
Improving Site-Sponsor Relationships: Proactive Strategies for Transparent Clinical Trials
This eBook outlines how clinical research sites and sponsors can effectively work together to improve their relationship.
Duke University Prioritizes Advarra eReg’s Site Centric Workflows within a Connected Research Ecosystem
Download the case study to learn more about how Advarra eReg’s site centric workflows streamlined Duke University’s clinical operations.
Returning to In-person Work: Sponsor Versus Site Viewpoints
An Advarra Trend Report found sites and sponsors alike are facing shifts as they continue to navigate the pandemic.
IRB Review of Phase I Healthy Research: Investigator and IRB Perspectives
Join our expert panel to learn about common pitfalls in Phase I study designs and IRB submissions and strategies to plan for success
Op-ed: Missing Elements of the Discussion on Decentralized Trials
Dr. Paul Evans, CEO of Velocity Clinical Research weighs in on what's missing in the discussion of decentralized trials.
Subscribe to our monthly email
Receive updates monthly about webinars for CEUs, white papers, podcasts, and more.
Advancing Clinical Research: Safer, Smarter, Faster™
Copyright © 2024 Advarra. All Rights Reserved.